Helen Giamarellou
Cited by
Cited by
Metallo-β-lactamases: a last frontier for β-lactams?
G Cornaglia, H Giamarellou, GM Rossolini
The Lancet infectious diseases 11 (5), 381-393, 2011
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe
M Souli, I Galani, H Giamarellou
Eurosurveillance 13 (47), 19045, 2008
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram …
D Plachouras, M Karvanen, LE Friberg, E Papadomichelakis, ...
Antimicrobial agents and chemotherapy 53 (8), 3430-3436, 2009
An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae in a Greek University Hospital: Molecular …
M Souli, I Galani, A Antoniadou, E Papadomichelakis, G Poulakou, ...
Clinical infectious diseases 50 (3), 364-373, 2010
Acinetobacter baumannii: a universal threat to public health?
H Giamarellou, A Antoniadou, K Kanellakopoulou
International journal of antimicrobial agents 32 (2), 106-119, 2008
Multidrug-resistant gram-negative infections
H Giamarellou, G Poulakou
Drugs 69 (14), 1879-1901, 2009
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control
Y Carmeli, M Akova, G Cornaglia, GL Daikos, J Garau, S Harbarth, ...
Clinical microbiology and infection 16 (2), 102-111, 2010
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial
LPG Derde, BS Cooper, H Goossens, S Malhotra-Kumar, RJL Willems, ...
The Lancet infectious diseases 14 (1), 31-39, 2014
Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster
A Antoniadou, F Kontopidou, G Poulakou, E Koratzanis, I Galani, ...
Journal of Antimicrobial Chemotherapy 59 (4), 786-790, 2007
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
I Karaiskos, H Giamarellou
Expert opinion on pharmacotherapy 15 (10), 1351-1370, 2014
Health care–associated native valve endocarditis: importance of non-nosocomial acquisition
N Benito, JM Miró, E de Lazzari, CH Cabell, A Del Río, J Altclas, ...
Annals of internal medicine 150 (9), 586-594, 2009
Redefining extended-spectrum β-lactamases: balancing science and clinical need
CG Giske, AS Sundsfjord, G Kahlmeter, N Woodford, P Nordmann, ...
Journal of Antimicrobial Chemotherapy 63 (1), 1-4, 2009
Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.
A Bauernfeind, I Stemplinger, R Jungwirth, H Giamarellou
Antimicrobial Agents and Chemotherapy 40 (1), 221-224, 1996
Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill
AF Mohamed, I Karaiskos, D Plachouras, M Karvanen, K Pontikis, ...
Antimicrobial agents and chemotherapy 56 (8), 4241-4249, 2012
Community-acquired methicillin-resistant Staphylococcus aureus infections
HC Maltezou, H Giamarellou
International journal of antimicrobial agents 27 (2), 87-96, 2006
Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?
EJ Giamarellos-Bourboulis, A Mega, P Grecka, N Scarpa, G Koratzanis, ...
Intensive care medicine 28 (9), 1351-1356, 2002
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective …
B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ...
The Lancet Infectious Diseases 17 (7), 726-734, 2017
Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia
EJ Giamarellos-Bourboulis, JC Pechere, C Routsi, D Plachouras, ...
Clinical Infectious Diseases 46 (8), 1157-1164, 2008
Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
G Cornaglia, M Akova, G Amicosante, R Cantón, R Cauda, JD Docquier, ...
International journal of antimicrobial agents 29 (4), 380-388, 2007
Central nervous system manifestations of Mycoplasma pneumoniae infections
S Tsiodras, I Kelesidis, T Kelesidis, E Stamboulis, H Giamarellou
Journal of Infection 51 (5), 343-354, 2005
The system can't perform the operation now. Try again later.
Articles 1–20